Joseph P. Lucia & Associates, LLC Mannkind Corp Transaction History

Joseph P. Lucia & Associates, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$2.62 - $4.45 $131 - $222	50 New	50 $0
Q4 2021 Feb 04, 2022	SELL	$4.05 - $5.37 $526 - $698	-130 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$1.79 - $4.04 $18,107 - $40,868	-10,116 Reduced 98.73%	130 $0
Q3 2020 Oct 20, 2020	SELL	$1.56 - $2.08 $202 - $270	-130 Reduced 1.25%	10,246 $19,000
Q2 2020 Jul 10, 2020	BUY	$0.94 - $2.21 $344 - $811	367 Added 3.67%	10,376 $18,000
Q1 2020 Apr 22, 2020	BUY	$0.84 - $1.76 $838 - $1,756	998 Added 11.08%	10,009 $10,000
Q4 2019 Jan 23, 2020	BUY	$1.14 - $1.49 $455 - $596	400 Added 4.65%	9,011 $12,000
Q3 2019 Oct 15, 2019	BUY	$1.04 - $1.44 $1,820 - $2,520	1,750 Added 25.51%	8,611 $11,000
Q2 2019 Jul 23, 2019	SELL	$1.09 - $1.88 $609 - $1,050	-559 Reduced 7.53%	6,861 $8,000
Q1 2019 May 02, 2019	BUY	$1.14 - $2.25 $8,458 - $16,695	7,420 New	7,420 $4.12 Million

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.